top biopharmaceuticals for glp-1 medication Women with a common hormonal disorder have few good treatment options. Could drugs help? As GLP-1 drugs boom, other

Compounded Semaglutide (GLP-1) is a once-weekly injectable medication that mimics a natural hormone involved in appetite regulation and blood sugar control

The Phase III clinical SURMOUNT-1 (NCT04184622) for tirzepatide, is expected to be completed in the first half of 2024

Switching to the oral small molecule glucagon-like peptide-1 (GLP-1) orforglipron after taking injectable GLP-1s helped patients maintain mostbut not allof their weight loss, according to a clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators

40%) and endoscopic response rates at week 48 (32% vs

[3] A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight (SURMOUNT-1)

Recently, BMS terminated the Phase III RELATIVITY-123 trial investigating the combination of Opdivo and the LAG-3 antibody relatlimab in a fixed dose for patients with microsatellite stable (MSS) metastatic colorectal cancer (mCRC)